US2022110866A1PendingUtilityA1

Compositions and methods for improving gastrointestinal absorption of electrolytes

Assignee: IGH NATURALS INCPriority: Jul 28, 2020Filed: Dec 22, 2021Published: Apr 14, 2022
Est. expiryJul 28, 2040(~14 yrs left)· nominal 20-yr term from priority
Inventors:Sourabh Kharait
A61K 9/0053A61K 33/06A61K 33/42A61K 47/14A61K 9/0095A61K 47/26A61K 31/702A61K 9/08A61K 47/42
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates generally to compositions and methods for improving gastrointestinal absorption function and correct deficiencies by preserving intestinal epithelial absorptive function. In particular, the compositions and methods for useful for improving gastrointestinal absorption of electrolytes.

Claims

exact text as granted — not AI-modified
1 . A drinkable aqueous solution comprising from about 0.5 g/L to about 20 g/L of one or more synthesized oligosaccharides selected from the group consisting of 2′-fucosyllactose, 3′-sialyllactose, 6′-sialyllactose, lacto-N-tetraose, monofucosyllacto-N-hexaose, lacto-N-fucopentaose and lacto-N-neotetraose, 150-800 mg/L of magnesium, and water, wherein the aqueous solution does not include more than about 1 g/L of lipids. 
     
     
         2 . The drinkable aqueous solution of  claim 1 , further comprising 100-1600 mg/L of sodium. 
     
     
         3 . The drinkable aqueous solution of  claim 2 , further comprising 80-800 mg/L of potassium, 
     
     
         4 . The drinkable aqueous solution of  claim 3 , further comprising 100-1000 mg/L of phosphorus and 20-800 mg/L of calcium. 
     
     
         5 . The drinkable aqueous solution of  claim 1 , which does not include more than about 5 g/L of proteins. 
     
     
         6 . The drinkable aqueous solution of  claim 5 , which does not include more than about 0.1 g/L of lipids. 
     
     
         7 . The drinkable aqueous solution of  claim 1 , wherein the lacto-N-fucopentaose is selected from the group consisting of lacto-N-fucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose IV and combinations thereof. 
     
     
         8 . The drinkable aqueous solution of  claim 1 , wherein the one or more synthesized oligosaccharides comprise 2′-fucosyllactose, 3′-sialyllactose, or the combination thereof. 
     
     
         9 . A solid composition prepared by drying the drinkable aqueous solution of  claim 1 .

Join the waitlist — get patent alerts

Track US2022110866A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.